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	The hospice industry requires public health policy in regards to quality of healthcare to improve the value of patient care. The first quality measures for hospices nationally were mandated by the Affordable Care Act (ACA) in 2010 and implemented in later years. This thesis will review the Hospice Item Set (HIS-7), Consumer Assessment of Healthcare Providers and Systems (CAHPS), and Service Intensity Add-On (SIA) focusing specifically on the Service Intensity Add-On. 
The history of policy development, scope of each policy, and compliance measures are discussed in this paper in detail. History in this case is over the past fives years and foreshadows the future quality indicators in hospice. This Master’s Essay heavily focuses on the first incentive policy in hospice quality, the Service Intensity Add-On, as well as its future usefulness, importance in relation to quality, and potential economic impact among hospices in the United States. The goal of this Master’s Essay is to emphasize the importance of national quality measures among medical professionals to increase the value of patient care and contain costs for treatment at end of life. 
Public Health Relevance
Hospice began in 1965 and did not have any mandated quality measures until the Affordable Care Act of 2010. Quality measures could reduce disparities in end of life care utilization. Many people in the aging community have mistrusted the healthcare system and chosen not to access hospice. Quality measures that will be available to the public (CAHPS) could encourage future use of services. Since a majority of the care is given in patient homes, there could be resistance in allowing hospice professionals into their private lives. On the other hand, this population could be fearful of receiving insufficient care. Also, a study demonstrated that the use of quality indicators increases performance among medical professionals in hospitals. Quality measures drive internal organization improvement strategies in delivering optimal care to patients. The hospice industry needs to instill the same standard of care similar to hospitals that have been accountable for quality care for over a decade. 
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Hospice Care is a holistic approach to caring for the terminally ill that focuses on providing comfort by relieving pain and symptoms, while removing any life extending treatments. Hospice benefits are provided to those who are certified by a physician as likely to die within the next six months. For these patients, there are either no additional treatment options, or the risks outweigh the benefits of further treatment. In 2013, hospice beneficiaries opted to receive care by the medical community in their own homes 66.6% of time (“NHPCO’s Facts and Figures”, 2014). Hospice benefits include a broad continuum of care that is responsive to each patient’s needs. A medical team develops and implements a plan of care for each patient, which may include physical care, counseling, medication, equipment, and supplies. The medical team is developed based on each patient and his or her needs. A typical team includes physicians, social workers, bereavement and spiritual counselors, home health aides, therapists, nurses, and volunteers at the bedside. Inpatient units are also available when caregivers are no longer able to provide efficient care and oversight in the home. The caregivers’ role is essential in supporting the patient; therefore, their physical, emotional, and spiritual state must be nurtured by hospice professionals during and after the death of a loved one on hospice benefit by bereavement specialists (“Medicare Hospice Benefits”, 2015).
Hospice care is a growing industry within the United States. In 2009, there were 1,341,391 individuals on hospice care; this number increased to 1,542,737 by 2013. Most of the primary diagnoses leading to the need for comfort measures from hospice are related to cancers, which comprise 36.5% of hospice admissions. Non-cancer diagnoses make up the other 63.5% of primary diagnoses such as dementia, heart disease, lung disease, debility unspecified, and end stage kidney disease (ESRD). In 2013, the average length of stay on hospice benefits was 72.6 days before death, with half of the patients being on service only18.5 days. The last days of life are often the most painful, and therefore 66.6% of Medicare beneficiaries on hospice benefit chose to receive care in the comfort of their own home with a family member or a close loved one. With a growing number of patients with chronic health conditions, hospices must follow national quality measures to meet demand and to deliver measurable and value-based care. The purpose of these standards is to hold hospices accountable, hence implementation of Hospice Item Set (HIS-7), Consumer Assessment of Healthcare Providers and Systems (CAHPS), and Service Intensity Add-On (SIA). These reportable measures are sent to the regulatory agency, Centers for Medicare and Medicaid Services (CMS), as mandated by the Affordable Care Act. This governmental entity should also plan on certifying hospice agencies that wish to provide the Medicare hospice benefit. This is due to the increase in demand for services to the population, specifically 87.2% of the population nationwide (“NHPCO’s Facts and Figures”, 2014).
For purposes of this literature review and case study it is important to consider the fact that the three quality initiatives addressed here effect different elements of care that together impact the overall quality of patient care in an organization. HIS-7 is a reportable measurement from the electronic medical record (EMR), CAHPS is a survey, and SIA is an addition to the payment structure. These policies all have the goal of placing value on patient care in hospice, but are not collectively similar to each other in terms of how they are implemented or measured. These are initiatives that fall under the hospice sector of the Affordable Care Act; before 2010, hospice was not managed by a regulatory body in sustaining high quality to patients.
2.0 	Centers for Medicare and Medicaid Services Role
There have been several federal regulations implemented within the hospice industry in the last few years. These regulations are primarily aimed at quality care and economic efficiency. The history of quality measures within hospice services was unknown before the Affordable Care Act. This paper describes several of the recent major hospice regulations that the hospice industry has seen in the past five years. Medicare beneficiaries eligible for or on hospice benefits have not historically been accounted for due to the absence of publicly reported measures on quality. A basic form of a reportable quality measurement was not devised and implemented until fiscal year 2014 by the Centers for Medicare and Medicaid Services (CMS).
The Centers for Medicare and Medicaid Services (CMS) is a regulatory agency that has created a system for reportable policies and regulations, as defined by the Affordable Care Act (ACA). All healthcare systems are now required to deliver standards of care in order to increase patient safety and quality of care, as well as to decrease costs. Since 2010, the hospice industry has been going through changes due to the implementation of the ACA. Section 3004 of the ACA mandated the Hospice Quality Reporting Program (HQRP) across all organizations within the United States (Centers for Medicare and Medicaid Services, 2015). Under HQRP, the Hospice Item Set (HIS-7) and the Consumer Assessment of Healthcare Providers and Systems (CAHPS) have become the central compliance measures with regards to clinical quality. This essay concentrates on the potential benefit of developing policies with internal organization financial incentives. The Service Intensity Add-On contributes to quality of patient care, but is administered as a payment reform instead of reported to CMS like the two components of HQRP.
Before the enactment of the ACA, the use of data-driven Quality Assurance and Performance Improvement (QAPI) program was the main source of quality measurement in hospices across the nation. The QAPI committee is an interdisciplinary team made up of a nursing director, physician, and at least three staff members. Under the Department of Health and Human Services, Public Health Title 42, chapter IV, is the statute that requires this committee to meet and discuss inadequacies of quality, monitor through feedback and systems-based, then develop plans of action (Code of Federal Regulations). Hospices in the United States have not been held accountable to provide high quality services until 2010. Before 2010, this industry was allowed to conduct services without national regulatory oversight. 
2.1	Formulation of Hospice Quality Policies
There was an absence of regulations set forth from legislation prior to the Office of Inspector General (OIG) recommendations. The Office of Inspector General (OIG), a part of the U.S Department of Health and Human Services, is a critical source for information that CMS uses to fuel change in Medicaid and Medicare. The OIG takes primary responsibility in uncovering waste, fraud, and abuse in healthcare (U.S. Department of Health & Human Services, 2016). CMS applies research and recommendations from the OIG to adjust and develop health policy. OIG’s findings have led to the recent change in payment within routine home care (RHC) in hospice by conducting investigative studies. The OIG found that nursing facilities with low complexity cases and extensive stays were receiving the same payment rate as RHC. Hospices noticed the revenue to be gained from easier cases with less intensive visits by staff and capitalized on seeking low-maintenance but long-stay patients. Their recommendation was to adjust the payment structure and to advise that Medicare should instead reimburse nursing facilities at lower rates. This study leads one to infer that patients with complex health prognoses and who receive RHC do not receive the amount of intensive visits necessary to stabilize patients, due to the lack of incentive from more intensive visits. The OIG recognized a problem with how the payment structure affected patient care, then encouraged CMS to legislatively make changes (Levinson, 2015). In turn, SIA was developed, and routine home care (RHC) per diem rates were restructured. A payment reform was proposed to restructure a financial incentive to encourage intensive visits in RHC. From OIG’s research, a loophole was found that enabled hospice organizations to take advantage of the financial incentive to care for low complexity patients in nursing facilities. This recommendation turned into a policy amendment to Section 3132(a) of the AFA influencing RHC per diem rates; hospices will be  paid at a higher rate during the first 60 days on hospice benefit for each day billed as of January 1, 2016 (“Implementation of the Hospice Payment Reforms”, 2015). Then, in order to increase the visit intensity within the last week of life, policymakers developed the SIA. This is an example of how policies similar to these two payment reforms are developed to indirectly influence quality of care in hospice; there are many systematic steps taken before a proposed policy turns into law. 
Quality Assurance and Performance improvement (QAPI) program is a systematic form of reportable measurements, including efficiency of physical symptom management, patient safety, structure and process of care, patient and family preferences, psychosocial management, care coordination and transitions, spiritual need assessment, bereavement, communication, and education. These areas are defined and measured in HIS-7, CAHPS, and SIA. CMS will now be able to compare hospices and set benchmarks by evaluating the outcomes of these policies (Zheng, Rokoske, Kirk, Lyda-McDonald, & Bernard, 2014).
2.2	HOSPICE ITEM SET
The Hospice Item Set (HIS) covers seven quality measures that involve administrative and clinical factors of services within hospice.  Beginning in July 2014, CMS developed a standardized instrument, HIS-7, which assesses seven process measures that encompass data documented by the medical team in patient electronic medical records (EMR). The hospice organizations’ EMR has continuously gained attention in meeting policy requirements reported to CMS in order to reduce costs. Regulatory bodies reimburse hospices for improving quality of care by changing practices of the medical team responsible for patients.  HIS-7 quality process measures include four bundles of reportable measures from the EMR (Centers for Medicare and Medicaid Services, 2014).
	First, pain status is measured during initial nursing assessment in the form of a pain screening that includes pain severity and the pain tool type. For process purposes, turnaround time is documented on the percent of those screening positive after having received a pain assessment in order to display their ability to manage pain in a short period of time. The goal is to initiate pain assessment within one day of screening positive for pain, since screening and assessment are important in symptom management and treatment (Centers for Medicare and Medicaid Services, 2014). The addition of pain screening and assessment as a national reportable measure to CMS represents the acknowledgement and approval of the hospice industries’ holistic approach to end of life care. By using an educated guess, one could assume HIS-7 was informed by a study that defined the problem of substandard pain management in end of life. “Assessing and Treating Pain in Hospices: Current State of Evidence-Based Practices”, a study conducted around the same time that the Affordable Care Act was introduced, evaluated the continuity of assessing and reassessing pain symptoms associated with a cancer diagnosis in a routine home care setting. Findings suggest 75% of patients in home care settings die with pain as a result of hospice providers not following recommendations of evidence-based practices. This was a problem due to the absence of documentation in regards to the type of assessment, pain intensity (no pain, mild pain, moderate pain, and severe pain), and reassessments carried out by nurses at follow-up visits (Herr et al., 2010). This study leaves one with the assumption that without documentation, medical professionals may not have been completing pain assessments and reassessments. Managing pain in the hospice industry is valuable in terms of patient care quality. These problems must be solved, because managing pain in the hospice industry is the foundation of holistically meeting the needs of patients who are experiencing terminal illness followed by death while on service. 
	The second of the HIS-7 quality measure areas is focused on respiratory status. Respiratory status is measured during initial nursing assessment, and again for those who screened positive for dyspnea. For process purposes, CMS cares most about the turnaround time in which those screening positive had received dyspnea treatment, as well as the type of treatment. The goal is to initiate treatment within one day of screening positive for dyspnea (Centers for Medicare and Medicaid Services, 2014). 
Third, documentation of treatment and discussion of beliefs and values fall under the documentation header of “preferences”. End of life preferences must be entered into the Electronic Medical Record (EMR) to inform the medical team. The discussions on life-sustaining treatment options by hospice staff must be documented and dated to demonstrate fulfillment. Life-sustaining discussions are on preferences regarding procedures surrounding CPR and hospitalizations, debriefing of Physician Orders for Life-Sustaining Treatment (POLST) form if already a part of medical record, and spiritual concerns. The purpose of these discussions is to ensure that patients’ needs and values are congruent with the plan of care (Centers for Medicare and Medicaid Services, 2014).
The last set of documentation has to do with the cessation or continuation of bowel regimen for patients depending on if current treatment includes the prescription of opioid medications. This is because a typical side effect of opioid use is constipation. If the bowel regimen was not initiated or continued, reasons why this did not occur must also be documented (Centers for Medicare and Medicaid Services, 2014).
Instead of seeking treatment for a terminal illness when death is expected within six months, beneficiaries wean off life-extending or therapeutic medications in exchange for comfort until discharge (or death). The HIS-7 is a time-sensitive compliance measure to assure hospice organizations are meeting standards of care. In order to develop future quality measures, a process measure was designed as a baseline for various areas of services provided. For hospices that did not participate in the reporting of HIS-7 measures to CMS, there was a 2% reduction in their fixed-income, or annual payment update, for the following fiscal year. In 2014, 90% of hospices reported HIS-7 process measures from their EMR while the other 10% of hospices did not report and therefore received the reduction of reimbursement (Plotzke et al., 2015).

2.3	Consumer Assessment of Healthcare Providers and Systems 
The Hospice Quality Reporting Program (HQRP) oversees both HIS-7 and another quality measure that is discussed in this section of the Master’s Essay. Beginning in 2015, the Affordable Care Act mandated that hospices implement the Consumer Assessment of Healthcare Providers and Systems (CAHPS) hospice survey distributed by trained third-party vendors under CMS, the regulatory body that created it. This is the first time hospice organizations will receive data from family members after their service is complete. The data is important for caregivers, the consumers, when considering their options for loved ones seeking the Medicare hospice benefit. This is a 47 question tool filled out by a family member of a deceased beneficiary. This is essentially a retrospective approach to improving care because competition among hospices in the same geographic will now have information derived from past consumer experiences of descendants. Hospices will now be obligated to improve areas with low scores and monitor improvement. Furthermore, it is important to note that because national data collection through use of this survey began less than a year ago, there is not yet a national database where the public is able to compare hospice ratings. The hospices are able to review internal results for quality improvement purposes, but should be cautious not to jump to conclusions. This is due to the inability to compare to other hospices that are geographically similar at this point in the process, since CAHPS is a brand new quality indicator in hospice (Centers for Medicare and Medicaid Services, 2014). For hospices that are noncompliant in participating in CAHPS, a negative effect in their payment update will occur, or essentially their annual income from CMS will follow in the beginning of fiscal year 2017 (Hackbarth, 2015). Hospice organizations that have 50 deaths or less are exempt from participating in the mandated requirement from CMS to distribute CAHPS. If this is not the case, the caregiver or family member fills out the survey from a third-party vendor, who then posts the CAHPS performance survey as a public report to allow comparison to other hospices based on the following 8 quality measures:
	Communication among hospice interdisciplinary team
	providing timely care
	treating patients and family member with respect
	providing emotional support
	supporting religious and spiritual beliefs
	providing help for symptom management
	providing information continuity
	informing caregiver and patient about pain medication side effects

There is also a 9th quality measure, which measures the hospice’s ability to train caregivers if the patient chooses routine home care (RHC). In order to highlight the impact of CAHPS within the hospice community, one must compare to other sectors of the healthcare system. The public data sets are accessible through Data.Medicare.gov, with survey domains including a variety of healthcare services provided for future consumers and caregivers to assess their options. The CAHPS data is combined, and then provides comparisons of hospitals, nursing homes, physicians, dialysis and home health with survey data specific to each sector of the healthcare system. The closest category to Hospice Care Compare is Home Health Compare, the most recently added category of quality comparisons across national, state-by-state, and agency data. Home health organizations are included if they are Medicare-certified and surveys are filled out by the family member 42 calendar days after the beneficiary has died. Though not all people with home health regularly die on service, this survey is for the families of beneficiaries who have and is most similar to the Hospice Survey. As of 2015, CMS will receive the Hospice Survey from approved third party vendors, and will soon be the next dataset added to Data.Medicare.gov; until then, home health is the most recent collection of information with three datasets distributed by CMS for the public to view (“CAHPS Hospice | FAQs”, 2016). This tool informs decisions across many different sectors of health by asking questions about experience, rather than performance, and is written in a way that individuals of different educational levels are able to understand (Centers for Medicare and Medicaid Services, 2015). Hospice is the last healthcare sector to adopt CAHPS; the outcomes and usefulness are unpredictable. A systematic review found there is no sufficient evidence that suggests CAHPS improves quality of care or quality improvement within organizations. Aspects of quality impact such as safety and patient centered care were not variables observed enough. A recommendation from an end of life perspective would be to look into these areas more instead of hospital mortality and surgeries (Fung et al., 2008). 


3.0 	Service Intensity Add-on (SIA)
Instead of measuring quality in the form of EMR reports or surveys, the newest addition to quality measurement is a payment reform at the end of life in routine home care (RHC). The Service Intensity Add-On (SIA) is the first financial incentive policy that will be nationally implemented under CMS as mandated by the Affordable Care Act. The SIA and RHC per diem rates are payment reforms that both involve changes to the way RHC is reimbursed. In order to understand the SIA, there must be an understanding of what RHC is, and how payment reform relates to visit intensity. Within hospice there are four level intensities of care; routine home care, general inpatient care, continuous care, and respite care. Those who decide to receive routine home care on hospice choose their place of residence to receive care. Place of residence may be in their private households, an assisted living facility, or a nursing facility. This is also the largest level of care, with 93.8% of beneficiaries choosing RHC in 2014 (National Hospice and Palliative Care Organization, n.d). RHC includes these settings and is the level of care SIA incentivizes to increase the number of patient visits. There are three levels that are not included in SIA; general inpatient care, continuous care, and respite care are not included in the policy. The first is general inpatient care, where services are provided in Medicare certified hospitals, hospice inpatient facilities, or nursing facilities that have a RN on staff 24 hours a day. In cases when inadequate provision of pain control or management of other symptoms is no longer feasible, patients are admitted to general inpatient care. The second level of continuous home care is not eligible for SIA either. This level of care is different from routine home care because it is defined as a time of pain or symptom crisis where the patient is watched closely for 8 to 24 hours. The third level is inpatient respite care which is not eligible for SIA, since at this level, an RN is on staff 24 hours and day. In place to relieve the primary caregiver for a maximum of five days in a row, the patient will stay in a hospital, hospice facility, or long term care facility (National Hospice and Palliative Care Organization, 2012). 
Routine home care in hospice service is receiving greater attention now than previously in the history of healthcare, through Affordable Care Act legislation of two different payment regimens (National Hospice and Palliative Care Organization, 2012). The RHC per diem rates were developed from the measurement of wage weighted minutes by CMS to find results based on the daily cost of care then compared to the “U-Shape” structure of visit intensity. Because per diem payment systems were structured by the ACA to stay constant throughout a patient’s entire period on hospice benefit, those with longer “episodes” were more profitable. Therefore, CMS proposed a rule in 2014 for the ACA to reimburse at a higher rate during the first 60 days of service, then a lower rate for the remainder of the patient’s use of hospice services. The problem with this rule is that RNs and MSWs were not being reimbursed at higher rates within the last days of life; a period of more intensive visits. This is where SIA comes into the equation of reimbursement for RHC visits. 
During 2012, the development of the SIA stemmed from CMS’s concern that in the last 2 days of life, about 14% of beneficiaries did not receive a RHC skilled visit. This outcome led the federal government to believe that many beneficiaries and their families were not being “actively engaged.” Taking the form of the U-Shaped curve, outpatient beneficiaries would have been expected to have a higher intensity of visits during the last days of life, but did not due to the lack of financial incentive for RNs and MSWs (Department of Health and Human Services (DHHS), 2015).
An analysis of intensive visits to outpatient beneficiaries at end of life was conducted in 2013, in which resource use throughout a beneficiary’s period on hospice services was measured via hospice claims data. The analysis demonstrated higher utilization of resources in the first two days of Hospice Benefit and six days preceding death on services. This means the cost of care is higher at the end of life due to higher utilization of resources, yet hospice organizations were not being reimbursed at higher rates during these periods of service. Unfortunately, this has led to 50% of beneficiaries not receiving visits from a social worker or registered nurse in the last 7 days of life, and 30% not receiving a skilled visit on the day of death in 2013. Abt Associates, the primary investigators who reported these findings to CMS, found that 14% of patients who died on service did not receive a visit from skilled hospice staff in the last two days of life in 2012 (Department of Health and Human Services (DHHS), 2015).
CMS gathered the findings from Abt Associates then proposed a payment reform rule in 2014 to address the lack of reimbursement for visit intensity by RNs or MSWs. The rule, also known as the SIA, has intentions to increase intensive visits during the last days of life. In doing so, the payment system was revised regarding RHC payment rates within the last 7 days of a patient’s life based on eligibility for reimbursement through SIA as outlined:
	Type of hospice visits include registered nurse and social worker
	Number of days visits are measured
	The visit type is routine home care (RHC) level of care
	Measure focus on presence or absence of one visit or the average number of visits received
The eligibility for reimbursement from CMS is stringent. Each patient on routine home care is able to be visited up to four hours per day by a RN or MSW. This financial incentive policy was developed into a final rule and enacted January 1, 2016. The above eligibility criteria will be the foundation of using claims-based indicators of quality.  
3.1	projection of sia impact on hospice organizations
3.1.1	Quality Impact of the Service Intensity Add-On (SIA) 
	The Service Intensity Add-On is the first incentive policy in the history of hospice regarding quality in hospice. By increasing the number of visits by registered nurses (RN) and social workers (MSW) in the last week of a patient’s life, the ultimate outcome in patient care is better symptom management. The ACA adopted the idea of financial incentives from CMS’s Premier Hospital Quality Incentive Demonstration, a pilot study measuring symptom management. In 2003, hospitals were reimbursed with a bonus payment from Medicare if five diagnoses had high total performance rates surrounding process and outcomes scores concerning cardiovascular health conditions, pneumonia, and hip and knee replacements (Centers for Medicare and Medicaid Services, 2011). Studies found that financial incentives did not have an impact on patient outcomes thereafter. However, low performing organizations improved after amending reimbursement methods in 2006 (Nix, 2013). The similarity between SIA and this pilot study are that both financially incentivize an organization to report certain processes. In hospice, the process is hours of intensive visits. A major difference is that the pilot study designated hospitals responsible for outcomes, but there is not a similar measurable outcome in hospice pertaining to SIA. The SIA does not place accountability on hospices to produce outcomes pertaining to symptom management at end of life. The economic impact of SIA was projected at a local Pittsburgh hospice through an analysis of EMR data of past visits with an RN or MSW for end of life patients. 
3.1.2	Projection of SIA Economic Impact Report
After analyzing the importance of visits within the last days of life, CMS created a new policy that focused on care within a beneficiary’s last days of life. The SIA is one of the two payments reforms. The RHC per diem rates payment reform was a structural change in the ACA, and SIA is a new incentive payment reform. CMS developed a policy to incentivize in-person visits to patients on RHC in their final days of life. Starting January 1, 2016 hospice visit will be eligible for this payment if they meet the following criteria:
	The visit type is routine home care (RHC) level of care. 
	The visits occur during the last seven days of life 
	The patient is discharged due to death from hospice services
	Service is provided in-person by a registered nurse (RN) or social worker (MSW) and does not exceed four hours a day
3.1.2.1	Background

While at a local Pittsburgh hospice, an analysis was conducted to project the financial impact on the organization after SIA policy implementation. There has historically been an absence of incentives through CMS in acknowledging care for patients in their last days of life.  Under new SIA policy, the hospice industry will be recognized for carrying out high performance services to patients on Medicare’s hospice benefit in beneficiaries’ final days of life.
3.1.2.2	Methods

Data was gathered from the Electronic Medical Record (EMR) of a Pittsburgh local hospice to conduct a retrospective analysis of potential reimbursement from CMS with regards to SIA; the incentive policy that went live January 1, 2016. This analysis included patient visits by a Registered Nurse (RN) or Social Worker (SW) from July 1, 2015 to December 29, 2015 (roughly 5 months). The patient cohort was defined using SIA eligibility, specifically, the list above in section 3.1.2 Projection of SIA Economic Impact Report. 
	The beginning dataset included 20,741 RN or MSW visits; after applying the policy criteria, it was determined there were 2,495 visits that met SIA criteria. This number was used to project a financial reimbursement impact on this hospice organization over the next fiscal year. Visits were excluded for the following reasons:
1. Non-Medicare financial classification
2. No-Pay Medicare
3. Not routine home care (RHC)
4. Patient was not discharged due to death
5. Visit believed to be wrongly classified (e.g. routine in-person after death of 	patient)
6. Visits that did not occur within the last 7 days of life.
7. Visits that start before midnight on day 1 and end after midnight on day 2.
8. Visit hours that exceeded 4 hours per day.  
The exclusion criteria were applied to get an estimate of total visit hours that would have applied for SIA reimbursement. These hours were then multiplied by the SIA rate to get an estimate of the total potential reimbursement amount.  Payment structure of the SIA reimbursement rate is based off of the current hospice continuous home care (CHC) hourly rate of $39.37 for up to four hours a day
3.1.2.3	Results

After applying all exclusion criteria, it was determined that between July 1, 2015 and December 29, 2015 there were 3,007 total hours and 2,001 total patient days eligible for the SIA payment. These included 574 unique patients who received in-person patient care by registered nurses or social workers in the final 7 days of their lives. Of the 574 eligible patients, there were 2,495 intensive visits by RNs and MSWs that qualified for the continuous care hourly rate. There was an estimated total additional SIA payment of $118,396 projected in five months.   
	Within the Local Pittsburgh Hospice, 86 out of the 2,001 patient days, were lost due to disqualification under the 4-hour cap of daily visit time by a RN or MSW. Patient days are each day a patient on RHC receives care from a RN and MSW within the study timeframe. Up to 4 hours were included in one patient day, and if the hours of intensive visits exceeded this cap they were not included. This is equivalent to the absence of a financial incentive for 181.58 hours of service due to exceeding the cap, for a total reimbursement loss of $7,148.80. 
	Of the 106 patient days that hit the four-hour limit to qualify for SIA reimbursement, there were 20 patient days out of 2,001 (about 1%) that would receive the full incentive reimbursement possible for the given day. The other 86 days hit the 4-hour cap, but also went over the amount of hours that would be reimbursed through SIA.
	The analysis projected a reimbursement from CMS to a local Pittsburgh hospice that totaled $118,396 over 3,007 hours. This averages $23,679 per month. The organization would expect an additional income of about $5,920 per week, and more specifically, $846 per day.

Table 1: Visit Hours Per Day from 8/7/15 to 12/18/15 in Local Pittsburgh Hospice
	Projection by hour
Patient days	2001	2001	2001	2001	2001










Instead of earning CMS per-diem rates for patient care, there will be an extra incentive leading to an extra $118,396 over the period of five months if the SIA payment reform had been in place. This is an estimated $284,150 additional reimbursement in 12 months for end of life visits. Under new federal reimbursement policy, this hospice will begin to earn extra revenue. These results are based off of a baseline environment without any intervention based on SIA reimbursement. It is likely that an intervention based on SIA payment would lead to increased SIA payment. For example, an intervention could focus on increasing the average number of hours per patient day. By increasing the current visit hours per day (refer to Table 2) from 1.5 hours to 2 hours, there would be an increase from 37.6% to 50% potential for full reimbursement through the SIA policy. The extra income from visit intensities could be used to staff more RNs and MSWs in order to meet the demand of patients. There is not external data available that suggests patients are dissatisfied with services from lack of intensive visits (hence the CAHPS survey to measure quality of care through experience with staff). 
With the current visit hours per day averaging 1.502 hours per patient day, the local Pittsburgh hospice now has an analysis that provides baseline data. Each RN and MSW has the opportunity to reach 4 hours per patient day. Visit intensity is an area that could be concentrated on due to the opportunity for RHC quality and financial growth in the organization. Financial incentives exist to encourage hospice organizations, but more importantly, the patient should theoretically receive more value-based care. 
3.1.2.5	Recommendations

A plan should be developed to reach full SIA reimbursement by discussing clear-cut short, medium, and long-term goals with core management. In order for core management to have an affect on how RNs and MSWs react to SIA, the local Pittsburgh hospice must have an organized focus and acknowledgement of where it stands in terms of priority. First, this analysis could be presented to organizational leadership in order to determine their satisfaction with the natural state of 1.502 hours per patient day. Leadership could assume the responsibility of developing a program to emphasize increasing hours per patient day. In the case that leadership positions take an interest in placing SIA on the agenda, RNs and MSWs will become important players in carrying out initiatives to reach goals of daily patient visit hours. Second, instead of taking the financial incentives and dollars available for the organization, the increase of RN and MSW visit intensity must be presented based off of the ethics and beliefs of the organization. In order to maximize beneficence, RNs and MSWs must understand how valuable their visits are within the last days of life. There is a risk of maleficence if individuals neglect to visit or irregularly check on their patients within the most service-intensive days at end of life. Finally, while focusing on value-based beliefs pertaining to RN and MSW visits at end of life, leadership could also mention maximizing the amount of hours spent with each patient to reach the predetermined average daily goal. In other words, the organization must instill beliefs through education in RNs and MSWs that visits at end of life are valuable to the patient and culture of the organization, as well as of financial benefit. 
Further, not only should RNs and MSWs be educated and aware of SIA, but also the entire hospice staff must be held accountable to carry out such a policy set forth by regulatory bodies. CMS is now acknowledging the value of hospice medical staff members and their time with patients; everyone in the organization must be aware of the SIA, which could be accomplished via educational sessions for all staff. Administrative and medical staff should have a similar understanding as to how the SIA will directly affect patients when carried out correctly. Post-educational session surveys will be used to measure staff competence in defining what SIA is, and how it effects everyone in the organization. 
Finally, the most quantifiable measure that could be carried out within the hospice organization is an “assess adjust” intervention. Each RN and MSW is recommended to report monthly feedback to clinical leaders that states the number of hours hit last month. The clinical leaders could then reevaluate the individual goals of each RN and MSW compared to their monthly report. For example, if an RN hit 45% of potential hours set forth from goals, the opportunity to visit more would be discussed with the nurse administrator. This is an intervention approach in which incremental changes can improve the wealth of the organization and health of patients over a long period of time.
3.1.3	Future of the Hospice Quality Reporting Program (HQRP)
A broad goal of hospice is to produce better care by providing comfort instead of curative treatment at the end of life. The whole premise of The Hospice Quality Reporting Program is to have the ability to compare hospice organizations across the nation and how quality affects providers, consumers, and payers. 
The EMR is used to meet requirements of HIS-7, whereas post-descendent surveys are used in CAHPS. Both of these quality initiatives fall under HQRP. HIS-7 will give CMS the means to interpret and compare hospices to each other in terms of their delivery of care and meeting requirements that apply to a high volume of patients on Medicare hospice benefit. The CAHPS data from fiscal year 2015-2016 must be used as baseline data to transform and improve care coordination and responsiveness to patients and their families. This is a measure that could be useful in the Quality Department’s strategic plan to improve caregiver and patient experiences in the future, based on survey scores from patient and family experiences with hospice services. There may be trends in the way care is provided that decrease the effectiveness and efficiency of services and satisfaction with quality of care. Between these two initiatives under HQRP, hospice is drastically changing due to lack of national quality indicators before the ACA. The initiation of quality measure changes the public’s view from hospice having a negative stigma to becoming more appealing. 
First, due to hospice services gaining interest from the aging population, generalized education must be spread throughout the community. This should pertain to information about the availability of skilled-visits around-the-clock, types of spiritual and emotional support for all individuals involved, education surrounding stages of death and instilling realistic expectations, and the benefits of choosing pain management medication compared to curative treatment.. Second, a consistent trend within various populations surround the issue of mistrust in the medical system. Hospice has a challenge to break down barriers while increasing the credible portals of information. A study found that consumers in order from greatest to least trusted; doctor or doctor’s office, internet, assisted living facilities or nursing homes, hospitals, and those with previous experience receiving hospice services. Third, in addition to building trust with consumers, multiple variables defined in CAHPS correlates with greater satisfaction in routine home care by caregivers. The medical teams must be specialized in informing caregivers about the patient’s condition and medications in a consistent and clear manner. The spirituality component of hospice is integrated with displaying evidence to the caregiver that the patient’s anxiety and pain are managed and that the emotional support for caregivers is available receding the patient’s death (Balfour, Berry, & Ross, 2015).
Overall, hospice organizations must internally create a culture that is both patient and caregiver centered, thinking about each consumer on an individual basis will enable optimal care. The organization cannot be driven by HQRP and payment reform, instead, the culture must match the underlying importance of quality care assurance. This foundation will lead to increased public awareness, attractiveness of services, and desirability of partnerships with other healthcare systems. 

4.0 	Discussion/Conclusion/implications
Because quality measurement policies for hospices in the United States have only been in legislature since 2010, there is not yet a large enough database for a national comparison of the quality of care. CMS’s addition of the Hospice Quality Reporting Program (HQRP) will equip future groundbreaking development and implementation of policies in this area of healthcare. In order to take on change, quality improvement measures and systems-based must take place; these are where quality departments become assets in improving patient outcomes and increasing revenue. This paper has discussed the current quality integrated policies in hospices nationwide, and has attempted to project how policy changes may directly affect the functioning of one healthcare organization. There are many different ways to define and solve problems by first using available data in the EMR, and then further diagnosing areas of significance or profitability. 
4.1	Recommendations
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